Neuberger Berman Group’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Neuberger Berman Group’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-7,541	Closed	-$672K	–	1849
2017 Q3	$672K	Buy	+7,541	New	+$573K	﹤0.01%	1235
2016 Q4	–	Sell	-12,500	Closed	-$751K	–	1675
2016 Q3	$751K	Buy	12,500 +3,500	+39%	+$202K	﹤0.01%	1174
2016 Q2	$460K	Buy	+9,000	New	+$385K	﹤0.01%	1260

Other funds holding ONCE

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Neuberger Berman Group's ONCE Position: Q4 2017 in Review

Neuberger Berman Group sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2017, closing a stake of 7,541 shares — an estimated $672K sold.

Neuberger Berman Group first reported a position in ONCE in Q2 2016 and held it in 3 quarters. The position peaked at $751K in Q3 2016. 160 funds tracked by Wall St. Rank hold ONCE as of Q4 2017.

Neuberger Berman Group reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
Neuberger Berman Group sold 7,541 Spark Therapeutics, Inc. Common Stock shares in Q4 2017, an estimated $672K.
Neuberger Berman Group first reported a position in Spark Therapeutics, Inc. Common Stock in Q2 2016 and held it in 3 quarters.
Neuberger Berman Group's Spark Therapeutics, Inc. Common Stock position peaked at $751K in Q3 2016.
160 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2017.

Based on Neuberger Berman Group's 13F filing for Q4 2017, filed 14 Feb 2018.